Healthcare, Regulatory and Reimbursement Landscape - South Korea
NEW YORK, Aug. 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Healthcare, Regulatory and Reimbursement Landscape - South Korea
http://www.reportlinker.com/p0941765/Healthcare-Regulatory-and-Reimbursement-Landscape---South-Korea.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics
Healthcare, Regulatory and Reimbursement Landscape - South Korea
Summary
GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - South Korea". The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of South Korea. The report identifies the key trends in the healthcare market of South Korea. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of South Korea. Most importantly, the report provides valuable insights on the trends and segmentation of pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.
The population of South Korea has been increasing with a CAGR of 0.4% from 2005-2010. As in most developed countries, South Korea also has increasing elderly population. Approximately 16% of the total population was above the age of 65 years in 2010. Due to the increasing elderly population the pharmaceutical market is expected to grow but it has been hindering the growth of the economy. It has one of the world's highest population densities.
The pharmaceutical market grew at Compound Annual Growth Rate (CAGR) of 7% from 2005 to 2010. The market is estimated to reach $28.1 billion in 2020. This reflects significant opportunities for foreign investors and their Research and Development (R&D) partners. The market for medical devices in Korea is one of the largest markets in Asia due to the increasing elderly population and subsequent increase in the demand for healthcare products and services. The medical device market in South Korea was valued at approximately $3 billion in 2005. It grew at a CAGR of 2.8% from 2005 to 2010. The market is predicted to reach $5.7 billion by 2020.
The positive trend in the healthcare market of South Korea can be attributed primarily to -
- Increasing elderly population
- Universal healthcare insurance
- High degree of access to healthcare facilities
Scope
The report provides information on the healthcare, regulatory and reimbursement landscape of South Korea. The scope includes -
- Overview of the pharmaceutical and medical devices market of South Korea including the market size, market segmentation, key drivers and barriers for the market.
- Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market.
- Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs and medical devices for South Korea.
- A detailed analysis of the political and economic environment of South Korea including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities and challenges for growth that exist in the healthcare market of South Korea.
Reasons to buy
The report on South Korea comprehensively covers both the pharmaceutical and the medical devices market of South Korea. The report will enhance your decision making capability. It will allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market of South Korea.
- Drive revenues by understanding the key trends, and reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the South Korean healthcare market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market of South Korea.
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 Report Guidance 11
3 Overview of the Pharmaceutical and Medical Devices Market 12
3.1 Pharmaceutical Market 12
3.1.1 Market Overview 12
3.1.2 Supply Channels 15
3.1.3 Market Segments 16
3.1.4 Major Disease Areas 23
3.1.5 Major Players 25
3.2 Medical Device Market 48
3.2.1 Market Overview 48
3.2.2 Overview of the Top Five Segments 50
3.2.3 Major Players 61
3.3 Market Drivers and Barriers 84
3.3.1 Market Drivers 84
3.3.2 Market Barriers 85
4 Market Access 86
4.1 Reimbursement and Payer Landscape 86
4.1.1 Healthcare System 86
4.1.2 Reimbursement Process 87
4.1.3 Overview of Insurance Providers 90
4.1.4 Patient Share in Healthcare Spending 94
4.1.5 Pricing Policies 95
4.2 Regulatory Landscape 96
4.2.1 Overview of Regulatory Agencies 96
4.2.2 Drug Approval Process 97
4.2.3 New Device Approval Process 99
4.2.4 Licensing Process for Manufacturing 101
4.2.5 Licensing Process for Exports and Imports 102
4.2.6 Intellectual Property Rights Landscape 103
4.2.7 Clinical Trial Regulations 104
4.2.8 Pharmaceutical Advertising Regulations 105
4.2.9 Pharmacy Regulations 106
4.2.10 Labeling and Packing Regulations 107
5 Country Analysis 108
5.1 Political Environment 108
5.1.1 Political Structure 108
5.1.2 Analysis of the Current Political Environment 109
5.1.3 Healthcare Policy Initiatives 109
5.2 Economic Landscape 111
5.3 Economic Indicators 112
5.3.1 Gross Domestic Product 112
5.3.2 Gross National Income 115
5.3.3 Inflation 116
5.3.4 Currency Exchange Rate 120
5.3.5 Foreign Direct Investment 121
5.3.6 Foreign Exchange Reserves 122
5.3.7 Trade Balance 123
5.3.8 Government Structural Balance 125
5.3.9 Government Net Debt 127
5.3.10 Major Industries 129
5.3.11 Biotechnology Industry 130
5.4 Demographics 132
5.4.1 Population 132
5.4.2 Education and Literacy 148
5.4.3 Employment 150
5.4.4 Disease Burden 151
5.5 Healthcare Infrastructure 153
5.5.1 Healthcare Facilities 153
5.5.2 Healthcare Parameters 161
5.5.3 Environmental Health 164
5.5.4 Healthcare Personnel 167
5.6 Healthcare Expenditure 170
5.6.1 Overview 170
5.6.2 Major Components of Healthcare Spending 172
5.6.3 Share of the Public and Private Sector 174
5.6.4 Spending in Pharmaceutical R&D 175
5.7 Trade Associations 177
5.7.1 Korean Pharmaceutical Association (KPA) 177
5.7.2 Korea Pharmaceutical Manufacturers Association (KPMA) 177
5.7.3 Korean Hospital Association (KHA) 178
5.8 Trade Fairs 178
6 Opportunities and Challenges 179
6.1 Opportunities 179
6.2 Challenges 179
7 Appendix 181
7.1 Abbreviations 181
7.2 Bibliography 184
7.3 Methodology 187
7.3.1 Coverage 187
7.3.2 Secondary Research 187
7.3.3 Forecasting 188
7.3.4 Primary Research 188
7.3.5 Expert Panel Validation 188
7.4 Contact Us 188
7.5 Disclaimer 189
List of Tables
Table 1: Pharmaceutical Market ($bn), South Korea, 2005–2010 13
Table 2: Pharmaceutical Market ($bn), South Korea, Forecast 2011–2020 14
Table 3: Pharmaceutical Trade ($bn), South Korea, 2005–2010 15
Table 4: Generic Market ($bn), South Korea, 2005–2010 17
Table 5: Generic Market ($bn), South Korea, Forecast 2011–2020 17
Table 6: Drugs Going Off-Patent, Revenues ($bn), Global, 2011–2014 18
Table 7: Biologics Market ($bn), South Korea, 2005–2010 20
Table 8: Biologics Market ($bn), South Korea, Forecast 2011–2020 21
Table 9: Over-the-Counter and Prescription Drugs, South Korea, Market Share (%), 2005–2010 22
Table 10: Major Disease Areas, South Korea, Expenditure ($m), 2007 23
Table 11: Major Products, Green Cross Holdings Corporation, South Korea, 2012 26
Table 12: Late Stage Pipeline, Green Cross Holdings Corporation, South Korea, 2012 26
Table 13: Major Products, Yuhan Corporation, South Korea, 2012 30
Table 14: Late Stage Pipeline, Yuhan Corporation, South Korea, 2012 30
Table 15: Major Products, Hanmi Pharmaceutical Co, South Korea, 2012 35
Table 16: Major Products, Jeil Pharmaceutical Co, South Korea, 2012 39
Table 17: Late Stage Pipeline, Jeil Pharmaceutical Co, South Korea, 2012 40
Table 18: Major Products, Dongwha Pharm Co, South Korea, 2012 44
Table 19: Late Stage Pipeline, Dongwha Pharm Co, South Korea, 2012 44
Table 20: Medical Device Market ($bn), South Korea, 2005–2010 48
Table 21: Medical Device Market ($bn), South Korea, Forecast, 2011–2020 49
Table 22: Medical Device Market, South Korea, Segments, Revenue ($m), 2010 50
Table 23: Ophthalmic Devices Market ($m), South Korea, 2005–2010 51
Table 24: Sales Trends for Major Players*, Ophthalmic Devices, South Korea, 2010 52
Table 25: Orthopedic Device Market ($m), South Korea, 2005–2010 53
Table 26: Sales Trends for Major Players*, Orthopedic Devices, South Korea, 2010 54
Table 27: Nephrology and Urology Devices Market ($m), South Korea, 2005–2010 55
Table 28: Sales Trends for Major Players*, Nephrology and Urology Devices, South Korea, 2010 56
Table 29: In Vitro Diagnostics Device Market ($m), South Korea, 2005–2010 57
Table 30: Sales Trends for Major Players*, In Vitro Devices, South Korea, 2010 58
Table 31: Dental Devices Market ($m), South Korea, 2005–2010 59
Table 32: Sales Trends for Major Players*, Dental Devices, South Korea, 2010 60
Table 33: Major Medical Device Companies, Revenue ($m), South Korea, 2010 61
Table 34: Major Products, Siemens Healthcare, Revenue ($m), 2012 62
Table 35: Late Stage Pipeline, Siemens Healthcare, 2012 63
Table 36: Late Stage Pipeline, GE Healthcare, 2012 72
Table 37: Major Products, Baxter International Inc, South Korea, 2012 76
Table 38: Major Products, Roche, Global Revenues ($m), 2012 82
Table 39: Late Stage Pipeline, Roche, 2012 82
Table 40: Dossier Requirements for Biosimilar Approval, South Korea 89
Table 41: Private and Public Healthcare Schemes, South Korea, 2008 93
Table 42: Healthcare Spending, South Korea, Patient Share (%), 2005–2010 95
Table 43: Classification of Medical Devices, South Korea, 2010 99
Table 44: Examples of Export of Patent Rights of Korean Pharmaceutical Companies, South Korea, 2011 104
Table 45: GDP Per Capita ($), South Korea, 2005–2010 112
Table 46: GDP Per Capita ($), South Korea, Forecast, 2011–2020 113
Table 47: GDP, South Korea, Annual Growth (%), 2005–2010 113
Table 48: GDP, South Korea, Annual Growth (%), Forecast, 2011–2020 114
Table 49: GNI Per Capita ($), South Korea, 2005–2010 115
Table 50: Average Consumer Price Index, South Korea, 2005–2010 116
Table 51: Average Consumer Price Index, South Korea, Forecast, 2011–2020 117
Table 52: Average Consumer Price, South Korea, Annual Change (%), 2005–2010 118
Table 53: Average Consumer Price, South Korea, Annual Change (%), Forecast, 2011–2020 119
Table 54: Currency Exchange Rate (KRW/$), South Korea, 2005–2010 120
Table 55: Foreign Direct Investment ($bn), South Korea, 2005–2010 121
Table 56: Foreign Exchange Reserves ($bn), South Korea, 2005–2010 122
Table 57: Exports of Goods and Services ($bn), South Korea, 2005–2010 123
Table 58: Imports of Goods and Service ($bn), South Korea, 2005–2010 124
Table 59: General Government Structural Balance ($bn), South Korea, 2005–2010 125
Table 60: General Government Structural Balance ($bn), South Korea, Forecast, 2011–2020 126
Table 61: General Government Net Debt ($bn), South Korea, 2005–2010 127
Table 62: General Government Net Debt ($bn), South Korea, Forecast, 2011–2020 128
Table 63: Major Industries, South Korea, Production ($bn), 2009 129
Table 64: Biotechnology Industry, South Korea ($bn), 2005-2010 130
Table 65: Population (m), South Korea, 2005–2010 132
Table 66: Population (m), South Korea, Forecast, 2011–2020 133
Table 67: Urban and Rural Population, South Korea, Share (%), 2005–2010 134
Table 68: Urban and Rural Population, South Korea, Share (%), Forecast, 2011–2020 135
Table 69: Age Groups, Population Distribution (%), South Korea, 2005–2010 136
Table 70: Age Groups, Population Distribution (%), South Korea, Forecast, 2011–2020 137
Table 71: Births (Per 1000 Population), South Korea, 2005–2010 138
Table 72: Mortality Rate (Per 1000 Population), South Korea, 2005–2010 139
Table 73: Children
Table 74: Major Causes of Mortality ('000s), South Korea, 2010 141
Table 75: Major Causes of Male Mortality ('000s), South Korea, 2008 142
Table 76: Major Causes of Female Mortality ('000s), South Korea, 2008 143
Table 77: Immunization Rate (%), South Korea, 2005?2010 144
Table 78: Gender Ratio (M/F), South Korea, 2005–2010 145
Table 79: Life Expectancy at Birth (Years), South Korea, 2005–2010 146
Table 80: Life Expectancy at Birth (Years), South Korea, Forecast, 2011–2020 147
Table 81: Levels of Education, South Korea, Students Enrolment Share (%), 2009 148
Table 82: Students Enrolled (m), South Korea, 2005–2010 149
Table 83: Unemployment Rate (%), South Korea, 2007–2010 150
Table 84: Major Diseases, South Korea, DALY (Per 100,000 Population), 2004 151
Table 85: Major Diseases, South Korea, Prevalence Rate (%), 2010 152
Table 86: Hospitals, South Korea, 2005–2010 154
Table 87: Hospitals by Bed Size, South Korea, 2005-2010 154
Table 88: Private Hospitals by Standard of Care, South Korea, 2008 155
Table 89: Public Hospitals by Standard of Care, South Korea, 2008 156
Table 90: Hospitals by Specialty, South Korea, 2005-2010 157
Table 91: Hospitals by Type of Service, South Korea, 2005-2010 158
Table 92: MRI Units in Hospitals (Per 100,000 Population), South Korea, 2005–2010 159
Table 93: CT Scan Units in Hospitals (Per 100,000 Population), South Korea, 2005–2010 160
Table 94: Beds (Per 1,000 Population), South Korea, 2005–2010 161
Table 95: Physicians (Per 1000 Population), South Korea, 2005–2010 162
Table 96: Physicians (Per 1000 Population), South Korea, Forecast, 2011–2020 163
Table 97: CO2 Emissions (Metric Tons), South Korea, 2005–2010 164
Table 98: Environmental Attributable Deaths (Per 100,000 Population), South Korea, 2004 165
Table 99: PM10 (Micrograms per Cubic Meter), South Korea, 2005?2010 166
Table 100: Nurses (Per 100,000 Population), South Korea, 2005–2010 167
Table 101: Pharmacists (Per 100,000 Population), South Korea, 2005–2010 168
Table 102: Dentists (Per 100,000 Population), South Korea, 2005–2010 169
Table 103: Healthcare Expenditure (% of GDP), South Korea, 2005–2010 170
Table 104: Healthcare Expenditure (% of GDP), South Korea, Forecast, 2011–2020 171
Table 105: Healthcare Expenditure, South Korea, Components (%), 2009 172
Table 106: Healthcare Expenditure, South Korea, Share of Service Providers (%), 2009 173
Table 107: Healthcare Expenditure, South Korea, Public-Private Share (%), 2005–2010 174
Table 108: Pharmaceutical R&D Expenditure (% of Sales), South Korea, 2005–2010 175
Table 109: Pharmaceutical R&D Expenditure (% Total Sales), South Korea, Forecast, 2011–2020 176
Table 110: Major Healthcare Trade Fairs, South Korea 178
List of Figures
Figure 1: Pharmaceutical Market ($bn), South Korea, 2005–2010 13
Figure 2: Pharmaceutical Market ($bn), South Korea, Forecast 2011–2020 14
Figure 3: Pharmaceutical Trade ($bn), South Korea, 2005–2010 15
Figure 4: Generic Market ($bn), South Korea, 2005–2010 16
Figure 5: Generic Market ($bn), South Korea, Forecast 2011–2020 17
Figure 6: Biologics Market ($bn), South Korea, 2005–2010 20
Figure 7: Biologics Market ($bn), South Korea, Forecast 2011–2020 21
Figure 8: Over-the-Counter and Prescription Drugs, South Korea, Market Share (%), 2005–2010 22
Figure 9: Major Disease Areas, South Korea, Expenditure ($m), 2007 23
Figure 10: Medical Device Market ($bn), South Korea, 2005–2010 48
Figure 11: Medical Device Market ($bn), South Korea, Forecast, 2011–2020 49
Figure 12: Medical Device Market, South Korea, Segments, Revenue ($m), 2010 50
Figure 13: Ophthalmic Devices Market ($m), South Korea, 2005–2010 51
Figure 14: Sales Trends for Major Players*, Ophthalmic Devices, South Korea, 2005–2010 52
Figure 15: Orthopedic Device Market ($m), South Korea, 2005–2010 53
Figure 16: Sales Trends for Major Players*, Orthopedic Devices, South Korea, 2005–2010 54
Figure 17: Nephrology and Urology Devices Market ($m), South Korea, 2005–2010 55
Figure 18: Sales Trends for Major Players*, Nephrology and Urology Devices, South Korea, 2005–2010 56
Figure 19: In Vitro Diagnostics Device Market ($m), South Korea, 2005–2010 57
Figure 20: Sales Trends for Major Players*, In Vitro Devices, South Korea, 2005–2010 58
Figure 21: Dental Devices Market ($m), South Korea, 2005–2010 59
Figure 22: Sales Trends for Major Players*, Dental Devices, South Korea, 2005–2010 60
Figure 23: Major Medical Device Companies, Revenue ($m), South Korea, 2010 61
Figure 24: Drivers and Barriers, Healthcare Market, South Korea 85
Figure 25: Evolution of the Healthcare System, South Korea, 1963-2000 86
Figure 26: Healthcare System, South Korea, 2011 87
Figure 27: Reimbursement Process, South Korea 88
Figure 28: Process of Inclusion of a New Drug in the Positive List, South Korea 89
Figure 29: Health Security System, South Korea 90
Figure 30: Distribution of Health Insurance Beneficiaries (%), South Korea, 2008 91
Figure 31: Structure of National Health Insurance, South Korea 92
Figure 32: Healthcare Spending, South Korea, Patient Share (%), 2005–2010 95
Figure 33: Organization of the Korean Food and Drug Association, South Korea 97
Figure 34: Drug Approval Process, South Korea 98
Figure 35: Medical Device Approval Process, South Korea 101
Figure 36: Clinical Trial Approval Process, South Korea 105
Figure 37: Major Health Reforms, South Korea, 2011 110
Figure 38: GDP Per Capita ($), South Korea, 2005–2010 112
Figure 39: GDP Per Capita ($), South Korea, Forecast, 2011–2020 113
Figure 40: GDP, South Korea, Annual Growth (%), 2005–2010 113
Figure 41: GDP, South Korea, Annual Growth (%), Forecast, 2011–2020 114
Figure 42: GNI Per Capita ($), South Korea, 2005–2010 115
Figure 43: Average Consumer Price Index, South Korea, 2005–2010 116
Figure 44: Average Consumer Price Index, South Korea, Forecast, 2011–2020 117
Figure 45: Average Consumer Price, South Korea, Annual Change (%), 2005–2010 118
Figure 46: Average Consumer Price, South Korea, Annual Change (%), Forecast, 2011–2020 119
Figure 47: Currency Exchange Rate (KRW/$), South Korea, 2005–2010 120
Figure 48: Foreign Direct Investment ($bn), South Korea, 2005–2010 121
Figure 49: Foreign Exchange Reserves ($bn), South Korea, 2005–2010 122
Figure 50: Exports of Goods and Services ($bn), South Korea, 2005–2010 123
Figure 51: Imports of Goods and Service ($bn), South Korea, 2005–2010 124
Figure 52: General Government Structural Balance ($bn), South Korea, 2005–2010 125
Figure 53: General Government Structural Balance ($bn), South Korea, Forecast, 2011–2020 126
Figure 54: General Government Net Debt ($bn), South Korea, 2005–2010 127
Figure 55: General Government Net Debt ($bn), South Korea, Forecast, 2011–2020 128
Figure 56: Major Industries, South Korea, Production ($bn), 2009 129
Figure 57: Biotechnology Industry, South Korea ($bn), 2005-2010 130
Figure 58: Status of Pharmaceutical/Bio Clusters, South Korea, 2011 131
Figure 59: Pharmaceutical and BT Industry Support Centers by Region, South Korea, 2011 131
Figure 60: Population (m), South Korea, 2005–2010 132
Figure 61: Population (m), South Korea, Forecast, 2011–2020 133
Figure 62: Urban and Rural Population, South Korea, Share (%), 2005–2010 134
Figure 63: Urban and Rural Population, South Korea, Share (%), Forecast, 2011–2020 135
Figure 64: Age Groups, Population Distribution (%), South Korea, 2005–2010 136
Figure 65: Age Groups, Population Distribution (%), South Korea, Forecast, 2011–2020 137
Figure 66: Births (Per 1000 Population), South Korea, 2005–2010 138
Figure 67: Mortality Rate (Per 1000 Population), South Korea, 2005–2010 139
Figure 68: Children
Figure 69: Major Causes of Mortality ('000s), South Korea, 2010 141
Figure 70: Major Causes of Male Mortality ('000s), South Korea, 2008 142
Figure 71: Major Causes of Female Mortality ('000s), South Korea, 2008 143
Figure 72: Immunization Rate (%), South Korea, 2005?2010 144
Figure 73: Gender Ratio (M/F), South Korea, 2005–2010 145
Figure 74: Life Expectancy at Birth (Years), South Korea, 2005–2010 146
Figure 75: Life Expectancy at Birth (Years), South Korea, Forecast, 2011–2020 147
Figure 76: Levels of Education, South Korea, Students Enrolment Share (%), 2009 148
Figure 77: Students Enrolled (m), South Korea, 2005–2010 149
Figure 78: Unemployment Rate (%), South Korea, 2005–2010 150
Figure 79: Major Diseases, South Korea, DALY (Per 100,000 Population), 2004 151
Figure 80: Major Diseases, South Korea, Prevalence Rate (%), 2010 152
Figure 81: Hospitals, South Korea, 2005–2010 153
Figure 82: Hospitals by Bed Size, South Korea, 2005-2010 154
Figure 83: Private Hospitals by Standard of Care, South Korea, 2008 155
Figure 84: Public Hospitals by Standard of Care, South Korea, 2008 156
Figure 85: Hospitals by Specialty, South Korea, 2005-2010 157
Figure 86: Hospitals by Type of Service, South Korea, 2005-2010 158
Figure 87: MRI Units in Hospitals (Per 100,000 Population), South Korea, 2005–2010 159
Figure 88: CT Scan Units in Hospitals (Per 100,000 Population), South Korea, 2005–2010 160
Figure 89: Beds (Per 1,000 Population), South Korea, 2005–2010 161
Figure 90: Physicians (Per 1000 Population), South Korea, 2005–2010 162
Figure 91: Physicians (Per 1000 Population), South Korea, Forecast, 2011–2020 163
Figure 92: CO2 Emissions (Metric Tons), South Korea, 2005–2010 164
Figure 93: Environmental Attributable Deaths (Per 100,000 Population), South Korea, 2004 165
Figure 94: PM10 (Micrograms Per Cubic Meter), South Korea, 2005?2010 166
Figure 95: Nurses (Per 100,000 Population), South Korea, 2005–2010 167
Figure 96: Pharmacists (Per 100,000 Population), South Korea, 2005–2010 168
Figure 97: Dentists (Per 100,000 Population), South Korea, 2005–2010 169
Figure 98: Healthcare Expenditure (% of GDP), South Korea, 2005–2010 170
Figure 99: Healthcare Expenditure (% of GDP), South Korea, Forecast, 2011–2020 171
Figure 100: Healthcare Expenditure, South Korea, Components (%), 2009 172
Figure 101: Healthcare Expenditure, South Korea, Share of Service Providers (%), 2009 173
Figure 102: Healthcare Expenditure, South Korea, Public-Private Share (%), 2005–2010 174
Figure 103: Pharmaceutical R&D Expenditure (% of Sales), South Korea, 2005–2010 175
Figure 104: Pharmaceutical R&D Expenditure (% Total Sales), South Korea, Forecast, 2011–2020 176
Figure 105: Government's Plan for Development of the Biotechnology Sector, South Korea, 2011 177
Figure 106: Opportunities and Challenges, Healthcare Market, South Korea 180
To order this report:
Diagnostics Industry: Healthcare, Regulatory and Reimbursement Landscape - South Korea
Check our Industry Analysis and Insights
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article